Blood Bank Reagents - New Base Plus Four Option Year Contract

Description This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the format Revolutionary FAR Overhaul (RFO) in Federal Acquisition Regulation (FAR) subpart 12.202, “Streamlined Procedures for Evaluation and Solicitation for Commercial Products and Commercial Services,” as supplemented with additional information included in this notice. This announcement constitutes only solicitation; quotes are being requested, and a written solicitation document will not be issued. This solicitation is issued as an RFQ. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC 2026-01). Note to CO: Obtain the most recent Federal Acquisition Circular (FAC) from ACQUISITION.GOV 🡪 Federal Acquisition Regulation This solicitation is set-aside for Full and Open Competition. The associated North American Industrial Classification System (NAICS) code for this procurement is 325413, with a small business size standard of 1250. The FSC/PSC is 6550. The Huntington VA Medical Center is seeking to establish a new multi-year contract for Blood Bank Testing Reagents. Please see below for additional information regarding this solicitation. The medical center is seeking to establish a base plus four option year contract. All interested companies shall provide quotations for the following: ITEM INFORMATION ITEM NUMBER DESCRIPTION OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT 0001 26.00 EA __________________ __________________ CONTROL,BLOOD BANK,ORTHO CONFIDENCE SERA,2 LVL LOCAL STOCK NUMBER: 6902096 0002 39.00 EA __________________ __________________ REAGENT,BLOOD BANK,FOR ORTHO MTS GEL TESTING,0.8%,10ML LOCAL STOCK NUMBER: 6902316 0003 13.00 EA __________________ __________________ KIT,MANUAL BLOOD BANK,RESOLVE PANEL A,AB ID,SOLN,3ML,0.8% LOCAL STOCK NUMBER: 6902317 0004 13.00 EA __________________ __________________ REAGENT,BLOOD BANK,AB ID,RESOLVE PANEL B,0.8%,3ML LOCAL STOCK NUMBER: 6902318 0005 13.00 EA __________________ __________________ REAGENT,BLOOD BANK,AB SCREENING,SURGISCREEN,3%,3 LVLS,10ML LOCAL STOCK NUMBER: 719100 0006 26.00 EA __________________ __________________ REAGENT,BLOOD BANK,AB SCREENING,AFFIRMAGEN 0.8%,10ML,2/KT MANUFACTURER PART NUMBER (MPN): 719201LOCAL STOCK NUMBER: 719201 0007 13.00 PG __________________ __________________ REAGENT,BLOOD BANK,REVERSE GR,A1 & B CELLS,3%,2 CELLS,10ML MANUFACTURER PART NUMBER (MPN): 719210LOCAL STOCK NUMBER: 719210 0008 13.00 PG __________________ __________________ REAGENT,BLOOD BANK,RBCS PANEL A,3ML,LIQ,DROPPER BOTTLE LOCAL STOCK NUMBER: 719510 0009 26.00 EA __________________ __________________ CONTROL,BLOOD BANK,COOMBS,10ML,DROPPER BOTTLE,WEAK,SOLN LOCAL STOCK NUMBER: 719810 0010 13.00 EA __________________ __________________ A2 Cells 1 x 10ML package 13 Annual volume (per package) Hershel “Woody” Williams VAMC STATEMENT OF WORK Blood Bank Testing Reagents I. Introduction Hershel “Woody” Williams VAMC Department of Pathology and Laboratory Medicine Services has a need to acquire blood bank testing reagents. These reagents are needed to perform transfusion testing that permit patients to receive blood and blood products safely, effectively and in a timely manner. The medical center is seeking to establish a new base plus four option year contract with the period of performance as follows: Base Year: 10-18-2026 to 10-17-2027 Option Year One: 10-18-2027 to 10-17-2028 Option Year Two: 10-18-2028 to 10-17-2029 Option Year Three: 10-18-2029 to 10-17-2030 Option Year Four: 10-18-2030 to 10-17-2031 II. Contractor Responsibilities Provide reagents necessary to conduct transfusion testing. Manifest/invoice of reagents shipped. Ship reagents as per the schedule. (d) A reagent user guide or similar documentation will be provided. The manual shall include the testing methodology used for each reagent, reagent reference ranges, and specimen requirements and any special handling required. (f) Transport container in such a manner as to ensure the integrity of the reagents Contractor will supply any special preservatives required for reagent preservation. All reagents shall be shipped in containers provided by contractor. (g) Contractor shall provide the VA laboratories with a means of communication to permit immediate inquiry regarding the status of pending reagent delivieries. (h) The VA Laboratories reserves the right to request the results of any proficiency testing that the contractor subscribes. (i) Contractor shall provide monthly billing for tests provided by the 20th of each month following the month in which the service was delivered. III. Quality Control Contractor shall notify the VA Laboratory Director (or designee) immediately by phone or email of any quality errors or delivery disruption. The notification shall be followed up by a written statement with recommended actions to take to remedy or resolve the situation. If the Contractor has defects or errors in their reagents that caused erroneous results, the Contractor shall supply replacement reagents at no charge to the VA or provide a credit to the VA. The choice of which will be discussed between the VA and the Contractor. For quality purposes, tests routinely performed in duplicate should be indicated. IV. Testing Changes The Contractor shall advise the Hershel “Woody” Williams VAMC Laboratory Director (or designee) of any changes in reagent methodology, procedures, reference values. If the contractor changes the reagent procedures or a critically important component of a reagent (e.g., an antibody, purified antigen, etc.) the contractor shall notify the VA Laboratory Director (or designee) pr…